nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—CYP2D6—Alzheimer's disease	0.415	1	CbGaD
Labetalol—CYP2D6—Rivastigmine—Alzheimer's disease	0.146	0.432	CbGbCtD
Labetalol—CYP2D6—Donepezil—Alzheimer's disease	0.117	0.345	CbGbCtD
Labetalol—CYP2D6—Galantamine—Alzheimer's disease	0.0751	0.223	CbGbCtD
Labetalol—Blood urea increased—Donepezil—Alzheimer's disease	0.00127	0.00622	CcSEcCtD
Labetalol—Atrioventricular block—Memantine—Alzheimer's disease	0.00126	0.00616	CcSEcCtD
Labetalol—Dry eye—Donepezil—Alzheimer's disease	0.00124	0.00608	CcSEcCtD
Labetalol—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.00123	0.00603	CcSEcCtD
Labetalol—Urinary retention—Galantamine—Alzheimer's disease	0.0012	0.00587	CcSEcCtD
Labetalol—Nightmare—Memantine—Alzheimer's disease	0.00118	0.00577	CcSEcCtD
Labetalol—Nightmare—Rivastigmine—Alzheimer's disease	0.00115	0.00565	CcSEcCtD
Labetalol—Blood urea increased—Memantine—Alzheimer's disease	0.00115	0.00564	CcSEcCtD
Labetalol—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00115	0.00563	CcSEcCtD
Labetalol—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.00115	0.00563	CcSEcCtD
Labetalol—Sleep disorder—Memantine—Alzheimer's disease	0.00102	0.00501	CcSEcCtD
Labetalol—Sleep disorder—Rivastigmine—Alzheimer's disease	0.001	0.0049	CcSEcCtD
Labetalol—Cardiac failure—Donepezil—Alzheimer's disease	0.000999	0.0049	CcSEcCtD
Labetalol—Hypoglycaemia—Donepezil—Alzheimer's disease	0.000999	0.0049	CcSEcCtD
Labetalol—Disorientation—Memantine—Alzheimer's disease	0.00099	0.00485	CcSEcCtD
Labetalol—Depression—Galantamine—Alzheimer's disease	0.000967	0.00474	CcSEcCtD
Labetalol—Affect lability—Donepezil—Alzheimer's disease	0.00096	0.00471	CcSEcCtD
Labetalol—Psychotic disorder—Donepezil—Alzheimer's disease	0.000952	0.00467	CcSEcCtD
Labetalol—Amnesia—Memantine—Alzheimer's disease	0.000942	0.00462	CcSEcCtD
Labetalol—Urinary retention—Donepezil—Alzheimer's disease	0.000927	0.00455	CcSEcCtD
Labetalol—Mood swings—Donepezil—Alzheimer's disease	0.000924	0.00453	CcSEcCtD
Labetalol—Amnesia—Rivastigmine—Alzheimer's disease	0.000922	0.00452	CcSEcCtD
Labetalol—Epistaxis—Galantamine—Alzheimer's disease	0.000914	0.00448	CcSEcCtD
Labetalol—Cardiac failure—Memantine—Alzheimer's disease	0.000907	0.00445	CcSEcCtD
Labetalol—Hypoglycaemia—Memantine—Alzheimer's disease	0.000907	0.00445	CcSEcCtD
Labetalol—Lethargy—Memantine—Alzheimer's disease	0.000903	0.00443	CcSEcCtD
Labetalol—Liver function test abnormal—Donepezil—Alzheimer's disease	0.0009	0.00441	CcSEcCtD
Labetalol—Ifenprodil—GRIN2B—Alzheimer's disease	0.000897	0.15	CrCbGaD
Labetalol—Abdominal pain upper—Donepezil—Alzheimer's disease	0.000891	0.00437	CcSEcCtD
Labetalol—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000891	0.00437	CcSEcCtD
Labetalol—Cardiac failure—Rivastigmine—Alzheimer's disease	0.000887	0.00435	CcSEcCtD
Labetalol—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.000887	0.00435	CcSEcCtD
Labetalol—Bradycardia—Galantamine—Alzheimer's disease	0.000886	0.00434	CcSEcCtD
Labetalol—Cramp muscle—Donepezil—Alzheimer's disease	0.000878	0.0043	CcSEcCtD
Labetalol—Affect lability—Memantine—Alzheimer's disease	0.000871	0.00427	CcSEcCtD
Labetalol—Hepatitis—Galantamine—Alzheimer's disease	0.00087	0.00427	CcSEcCtD
Labetalol—Hallucination—Galantamine—Alzheimer's disease	0.000866	0.00425	CcSEcCtD
Labetalol—Psychotic disorder—Memantine—Alzheimer's disease	0.000865	0.00424	CcSEcCtD
Labetalol—Oedema peripheral—Galantamine—Alzheimer's disease	0.000857	0.0042	CcSEcCtD
Labetalol—Affect lability—Rivastigmine—Alzheimer's disease	0.000852	0.00418	CcSEcCtD
Labetalol—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000846	0.00415	CcSEcCtD
Labetalol—Urinary retention—Memantine—Alzheimer's disease	0.000842	0.00413	CcSEcCtD
Labetalol—Visual impairment—Galantamine—Alzheimer's disease	0.000839	0.00411	CcSEcCtD
Labetalol—Mood swings—Memantine—Alzheimer's disease	0.000839	0.00411	CcSEcCtD
Labetalol—Urinary retention—Rivastigmine—Alzheimer's disease	0.000824	0.00404	CcSEcCtD
Labetalol—Angina pectoris—Donepezil—Alzheimer's disease	0.000821	0.00402	CcSEcCtD
Labetalol—Sweating increased—Donepezil—Alzheimer's disease	0.000821	0.00402	CcSEcCtD
Labetalol—Mood swings—Rivastigmine—Alzheimer's disease	0.00082	0.00402	CcSEcCtD
Labetalol—Liver function test abnormal—Memantine—Alzheimer's disease	0.000817	0.00401	CcSEcCtD
Labetalol—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000809	0.00396	CcSEcCtD
Labetalol—Flushing—Galantamine—Alzheimer's disease	0.000808	0.00396	CcSEcCtD
Labetalol—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.0008	0.00392	CcSEcCtD
Labetalol—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000791	0.00388	CcSEcCtD
Labetalol—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000791	0.00388	CcSEcCtD
Labetalol—Dysuria—Donepezil—Alzheimer's disease	0.000788	0.00386	CcSEcCtD
Labetalol—Cramp muscle—Rivastigmine—Alzheimer's disease	0.00078	0.00382	CcSEcCtD
Labetalol—Mental disorder—Galantamine—Alzheimer's disease	0.000763	0.00374	CcSEcCtD
Labetalol—Bronchospasm—Memantine—Alzheimer's disease	0.000753	0.00369	CcSEcCtD
Labetalol—Depression—Donepezil—Alzheimer's disease	0.000749	0.00367	CcSEcCtD
Labetalol—Angina pectoris—Memantine—Alzheimer's disease	0.000745	0.00365	CcSEcCtD
Labetalol—Sweating increased—Memantine—Alzheimer's disease	0.000745	0.00365	CcSEcCtD
Labetalol—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000736	0.00361	CcSEcCtD
Labetalol—Jaundice—Donepezil—Alzheimer's disease	0.000732	0.00359	CcSEcCtD
Labetalol—Sweating increased—Rivastigmine—Alzheimer's disease	0.000729	0.00357	CcSEcCtD
Labetalol—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000729	0.00357	CcSEcCtD
Labetalol—Muscle spasms—Galantamine—Alzheimer's disease	0.000728	0.00357	CcSEcCtD
Labetalol—Sweating—Donepezil—Alzheimer's disease	0.00072	0.00353	CcSEcCtD
Labetalol—Dysuria—Memantine—Alzheimer's disease	0.000715	0.00351	CcSEcCtD
Labetalol—Vision blurred—Galantamine—Alzheimer's disease	0.000714	0.0035	CcSEcCtD
Labetalol—Tremor—Galantamine—Alzheimer's disease	0.00071	0.00348	CcSEcCtD
Labetalol—Epistaxis—Donepezil—Alzheimer's disease	0.000709	0.00347	CcSEcCtD
Labetalol—Erectile dysfunction—Memantine—Alzheimer's disease	0.000705	0.00345	CcSEcCtD
Labetalol—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000703	0.00345	CcSEcCtD
Labetalol—Dysuria—Rivastigmine—Alzheimer's disease	0.0007	0.00343	CcSEcCtD
Labetalol—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000689	0.00338	CcSEcCtD
Labetalol—Bradycardia—Donepezil—Alzheimer's disease	0.000687	0.00337	CcSEcCtD
Labetalol—Malaise—Galantamine—Alzheimer's disease	0.000683	0.00335	CcSEcCtD
Labetalol—Vertigo—Galantamine—Alzheimer's disease	0.000681	0.00334	CcSEcCtD
Labetalol—Depression—Memantine—Alzheimer's disease	0.00068	0.00334	CcSEcCtD
Labetalol—Syncope—Galantamine—Alzheimer's disease	0.000679	0.00333	CcSEcCtD
Labetalol—Hepatitis—Donepezil—Alzheimer's disease	0.000675	0.00331	CcSEcCtD
Labetalol—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000671	0.00329	CcSEcCtD
Labetalol—Hallucination—Donepezil—Alzheimer's disease	0.000671	0.00329	CcSEcCtD
Labetalol—Palpitations—Galantamine—Alzheimer's disease	0.00067	0.00328	CcSEcCtD
Labetalol—Drowsiness—Rivastigmine—Alzheimer's disease	0.000667	0.00327	CcSEcCtD
Labetalol—Loss of consciousness—Galantamine—Alzheimer's disease	0.000666	0.00326	CcSEcCtD
Labetalol—Depression—Rivastigmine—Alzheimer's disease	0.000665	0.00326	CcSEcCtD
Labetalol—Oedema peripheral—Donepezil—Alzheimer's disease	0.000664	0.00326	CcSEcCtD
Labetalol—Hypertension—Galantamine—Alzheimer's disease	0.000654	0.00321	CcSEcCtD
Labetalol—Mirabegron—BCHE—Alzheimer's disease	0.00065	0.109	CrCbGaD
Labetalol—Visual impairment—Donepezil—Alzheimer's disease	0.00065	0.00319	CcSEcCtD
Labetalol—Epistaxis—Memantine—Alzheimer's disease	0.000643	0.00315	CcSEcCtD
Labetalol—Sweating—Rivastigmine—Alzheimer's disease	0.00064	0.00314	CcSEcCtD
Labetalol—Discomfort—Galantamine—Alzheimer's disease	0.000637	0.00312	CcSEcCtD
Labetalol—Agranulocytosis—Memantine—Alzheimer's disease	0.000637	0.00312	CcSEcCtD
Labetalol—Epistaxis—Rivastigmine—Alzheimer's disease	0.00063	0.00309	CcSEcCtD
Labetalol—Confusional state—Galantamine—Alzheimer's disease	0.000623	0.00306	CcSEcCtD
Labetalol—Bradycardia—Memantine—Alzheimer's disease	0.000623	0.00306	CcSEcCtD
Labetalol—Hepatitis—Memantine—Alzheimer's disease	0.000612	0.003	CcSEcCtD
Labetalol—Bradycardia—Rivastigmine—Alzheimer's disease	0.00061	0.00299	CcSEcCtD
Labetalol—Hypoaesthesia—Memantine—Alzheimer's disease	0.000609	0.00299	CcSEcCtD
Labetalol—Hallucination—Memantine—Alzheimer's disease	0.000609	0.00299	CcSEcCtD
Labetalol—Shock—Galantamine—Alzheimer's disease	0.000608	0.00298	CcSEcCtD
Labetalol—Oedema peripheral—Memantine—Alzheimer's disease	0.000603	0.00296	CcSEcCtD
Labetalol—Hepatitis—Rivastigmine—Alzheimer's disease	0.000599	0.00294	CcSEcCtD
Labetalol—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000598	0.00293	CcSEcCtD
Labetalol—Hallucination—Rivastigmine—Alzheimer's disease	0.000596	0.00292	CcSEcCtD
Labetalol—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000596	0.00292	CcSEcCtD
Labetalol—Alopecia—Donepezil—Alzheimer's disease	0.000596	0.00292	CcSEcCtD
Labetalol—Mental disorder—Donepezil—Alzheimer's disease	0.000591	0.0029	CcSEcCtD
Labetalol—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00059	0.00289	CcSEcCtD
Labetalol—Visual impairment—Memantine—Alzheimer's disease	0.00059	0.00289	CcSEcCtD
Labetalol—Erythema—Donepezil—Alzheimer's disease	0.000587	0.00288	CcSEcCtD
Labetalol—Hypotension—Galantamine—Alzheimer's disease	0.000578	0.00283	CcSEcCtD
Labetalol—Visual impairment—Rivastigmine—Alzheimer's disease	0.000577	0.00283	CcSEcCtD
Labetalol—Flushing—Memantine—Alzheimer's disease	0.000568	0.00279	CcSEcCtD
Labetalol—Muscle spasms—Donepezil—Alzheimer's disease	0.000565	0.00277	CcSEcCtD
Labetalol—Flushing—Rivastigmine—Alzheimer's disease	0.000556	0.00273	CcSEcCtD
Labetalol—Paraesthesia—Galantamine—Alzheimer's disease	0.000555	0.00272	CcSEcCtD
Labetalol—Vision blurred—Donepezil—Alzheimer's disease	0.000553	0.00271	CcSEcCtD
Labetalol—Tremor—Donepezil—Alzheimer's disease	0.00055	0.0027	CcSEcCtD
Labetalol—Somnolence—Galantamine—Alzheimer's disease	0.00055	0.0027	CcSEcCtD
Labetalol—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000545	0.00267	CcSEcCtD
Labetalol—Dyspepsia—Galantamine—Alzheimer's disease	0.000544	0.00267	CcSEcCtD
Labetalol—Alopecia—Memantine—Alzheimer's disease	0.000541	0.00265	CcSEcCtD
Labetalol—Mental disorder—Memantine—Alzheimer's disease	0.000537	0.00263	CcSEcCtD
Labetalol—Fatigue—Galantamine—Alzheimer's disease	0.000533	0.00261	CcSEcCtD
Labetalol—Malaise—Donepezil—Alzheimer's disease	0.00053	0.0026	CcSEcCtD
Labetalol—Alopecia—Rivastigmine—Alzheimer's disease	0.000529	0.0026	CcSEcCtD
Labetalol—Constipation—Galantamine—Alzheimer's disease	0.000529	0.00259	CcSEcCtD
Labetalol—Vertigo—Donepezil—Alzheimer's disease	0.000528	0.00259	CcSEcCtD
Labetalol—Benazepril—MTHFR—Alzheimer's disease	0.000527	0.0883	CrCbGaD
Labetalol—Syncope—Donepezil—Alzheimer's disease	0.000527	0.00258	CcSEcCtD
Labetalol—Mental disorder—Rivastigmine—Alzheimer's disease	0.000525	0.00257	CcSEcCtD
Labetalol—Erythema—Rivastigmine—Alzheimer's disease	0.000522	0.00256	CcSEcCtD
Labetalol—Loss of consciousness—Donepezil—Alzheimer's disease	0.000516	0.00253	CcSEcCtD
Labetalol—Feeling abnormal—Galantamine—Alzheimer's disease	0.00051	0.0025	CcSEcCtD
Labetalol—Hypertension—Donepezil—Alzheimer's disease	0.000507	0.00249	CcSEcCtD
Labetalol—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000506	0.00248	CcSEcCtD
Labetalol—Vision blurred—Memantine—Alzheimer's disease	0.000502	0.00246	CcSEcCtD
Labetalol—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000501	0.00246	CcSEcCtD
Labetalol—Tremor—Memantine—Alzheimer's disease	0.0005	0.00245	CcSEcCtD
Labetalol—Ill-defined disorder—Memantine—Alzheimer's disease	0.000495	0.00243	CcSEcCtD
Labetalol—Discomfort—Donepezil—Alzheimer's disease	0.000494	0.00242	CcSEcCtD
Labetalol—Quinapril—ACE—Alzheimer's disease	0.000494	0.0827	CrCbGaD
Labetalol—Vision blurred—Rivastigmine—Alzheimer's disease	0.000492	0.00241	CcSEcCtD
Labetalol—Body temperature increased—Galantamine—Alzheimer's disease	0.000489	0.0024	CcSEcCtD
Labetalol—Abdominal pain—Galantamine—Alzheimer's disease	0.000489	0.0024	CcSEcCtD
Labetalol—Tremor—Rivastigmine—Alzheimer's disease	0.000489	0.0024	CcSEcCtD
Labetalol—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000484	0.00237	CcSEcCtD
Labetalol—Confusional state—Donepezil—Alzheimer's disease	0.000483	0.00237	CcSEcCtD
Labetalol—Malaise—Memantine—Alzheimer's disease	0.000481	0.00236	CcSEcCtD
Labetalol—Oedema—Donepezil—Alzheimer's disease	0.000479	0.00235	CcSEcCtD
Labetalol—Vertigo—Memantine—Alzheimer's disease	0.000479	0.00235	CcSEcCtD
Labetalol—Syncope—Memantine—Alzheimer's disease	0.000478	0.00234	CcSEcCtD
Labetalol—Shock—Donepezil—Alzheimer's disease	0.000471	0.00231	CcSEcCtD
Labetalol—Palpitations—Memantine—Alzheimer's disease	0.000471	0.00231	CcSEcCtD
Labetalol—Malaise—Rivastigmine—Alzheimer's disease	0.00047	0.00231	CcSEcCtD
Labetalol—Vertigo—Rivastigmine—Alzheimer's disease	0.000469	0.0023	CcSEcCtD
Labetalol—Loss of consciousness—Memantine—Alzheimer's disease	0.000469	0.0023	CcSEcCtD
Labetalol—Syncope—Rivastigmine—Alzheimer's disease	0.000468	0.00229	CcSEcCtD
Labetalol—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000463	0.00227	CcSEcCtD
Labetalol—Palpitations—Rivastigmine—Alzheimer's disease	0.000461	0.00226	CcSEcCtD
Labetalol—Hypertension—Memantine—Alzheimer's disease	0.00046	0.00226	CcSEcCtD
Labetalol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000458	0.00225	CcSEcCtD
Labetalol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000456	0.00223	CcSEcCtD
Labetalol—Hypertension—Rivastigmine—Alzheimer's disease	0.00045	0.00221	CcSEcCtD
Labetalol—Discomfort—Memantine—Alzheimer's disease	0.000448	0.0022	CcSEcCtD
Labetalol—Hypotension—Donepezil—Alzheimer's disease	0.000448	0.0022	CcSEcCtD
Labetalol—Asthenia—Galantamine—Alzheimer's disease	0.000444	0.00218	CcSEcCtD
Labetalol—Confusional state—Memantine—Alzheimer's disease	0.000439	0.00215	CcSEcCtD
Labetalol—Discomfort—Rivastigmine—Alzheimer's disease	0.000439	0.00215	CcSEcCtD
Labetalol—Oedema—Memantine—Alzheimer's disease	0.000435	0.00213	CcSEcCtD
Labetalol—Paraesthesia—Donepezil—Alzheimer's disease	0.00043	0.00211	CcSEcCtD
Labetalol—Benazepril—ACE—Alzheimer's disease	0.00043	0.0719	CrCbGaD
Labetalol—Confusional state—Rivastigmine—Alzheimer's disease	0.000429	0.0021	CcSEcCtD
Labetalol—Shock—Memantine—Alzheimer's disease	0.000428	0.0021	CcSEcCtD
Labetalol—Dyspnoea—Donepezil—Alzheimer's disease	0.000427	0.00209	CcSEcCtD
Labetalol—Somnolence—Donepezil—Alzheimer's disease	0.000426	0.00209	CcSEcCtD
Labetalol—Oedema—Rivastigmine—Alzheimer's disease	0.000426	0.00209	CcSEcCtD
Labetalol—Diarrhoea—Galantamine—Alzheimer's disease	0.000423	0.00207	CcSEcCtD
Labetalol—Dyspepsia—Donepezil—Alzheimer's disease	0.000422	0.00207	CcSEcCtD
Labetalol—Hyperhidrosis—Memantine—Alzheimer's disease	0.000421	0.00206	CcSEcCtD
Labetalol—Shock—Rivastigmine—Alzheimer's disease	0.000419	0.00205	CcSEcCtD
Labetalol—Fatigue—Donepezil—Alzheimer's disease	0.000413	0.00203	CcSEcCtD
Labetalol—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000412	0.00202	CcSEcCtD
Labetalol—Pain—Donepezil—Alzheimer's disease	0.00041	0.00201	CcSEcCtD
Labetalol—Constipation—Donepezil—Alzheimer's disease	0.00041	0.00201	CcSEcCtD
Labetalol—Dizziness—Galantamine—Alzheimer's disease	0.000409	0.002	CcSEcCtD
Labetalol—Hypotension—Memantine—Alzheimer's disease	0.000407	0.00199	CcSEcCtD
Labetalol—Hypotension—Rivastigmine—Alzheimer's disease	0.000398	0.00195	CcSEcCtD
Labetalol—Feeling abnormal—Donepezil—Alzheimer's disease	0.000395	0.00194	CcSEcCtD
Labetalol—Vomiting—Galantamine—Alzheimer's disease	0.000393	0.00193	CcSEcCtD
Labetalol—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000392	0.00192	CcSEcCtD
Labetalol—Paraesthesia—Memantine—Alzheimer's disease	0.000391	0.00192	CcSEcCtD
Labetalol—Rash—Galantamine—Alzheimer's disease	0.00039	0.00191	CcSEcCtD
Labetalol—Dermatitis—Galantamine—Alzheimer's disease	0.00039	0.00191	CcSEcCtD
Labetalol—Dyspnoea—Memantine—Alzheimer's disease	0.000388	0.0019	CcSEcCtD
Labetalol—Headache—Galantamine—Alzheimer's disease	0.000387	0.0019	CcSEcCtD
Labetalol—Somnolence—Memantine—Alzheimer's disease	0.000387	0.0019	CcSEcCtD
Labetalol—Dyspepsia—Memantine—Alzheimer's disease	0.000383	0.00188	CcSEcCtD
Labetalol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000382	0.00187	CcSEcCtD
Labetalol—Urticaria—Donepezil—Alzheimer's disease	0.000381	0.00187	CcSEcCtD
Labetalol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000379	0.00186	CcSEcCtD
Labetalol—Salsalate—PTGS1—Alzheimer's disease	0.000379	0.0635	CrCbGaD
Labetalol—Body temperature increased—Donepezil—Alzheimer's disease	0.000379	0.00186	CcSEcCtD
Labetalol—Abdominal pain—Donepezil—Alzheimer's disease	0.000379	0.00186	CcSEcCtD
Labetalol—Somnolence—Rivastigmine—Alzheimer's disease	0.000378	0.00186	CcSEcCtD
Labetalol—Fatigue—Memantine—Alzheimer's disease	0.000375	0.00184	CcSEcCtD
Labetalol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000375	0.00184	CcSEcCtD
Labetalol—Pain—Memantine—Alzheimer's disease	0.000372	0.00182	CcSEcCtD
Labetalol—Constipation—Memantine—Alzheimer's disease	0.000372	0.00182	CcSEcCtD
Labetalol—Nausea—Galantamine—Alzheimer's disease	0.000367	0.0018	CcSEcCtD
Labetalol—Fatigue—Rivastigmine—Alzheimer's disease	0.000367	0.0018	CcSEcCtD
Labetalol—Pain—Rivastigmine—Alzheimer's disease	0.000364	0.00178	CcSEcCtD
Labetalol—Constipation—Rivastigmine—Alzheimer's disease	0.000364	0.00178	CcSEcCtD
Labetalol—Feeling abnormal—Memantine—Alzheimer's disease	0.000359	0.00176	CcSEcCtD
Labetalol—Mirabegron—CYP2D6—Alzheimer's disease	0.000357	0.0598	CrCbGaD
Labetalol—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000356	0.00174	CcSEcCtD
Labetalol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000353	0.00173	CcSEcCtD
Labetalol—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000351	0.00172	CcSEcCtD
Labetalol—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000348	0.00171	CcSEcCtD
Labetalol—Urticaria—Memantine—Alzheimer's disease	0.000346	0.00169	CcSEcCtD
Labetalol—Body temperature increased—Memantine—Alzheimer's disease	0.000344	0.00169	CcSEcCtD
Labetalol—Abdominal pain—Memantine—Alzheimer's disease	0.000344	0.00169	CcSEcCtD
Labetalol—Asthenia—Donepezil—Alzheimer's disease	0.000344	0.00169	CcSEcCtD
Labetalol—Pruritus—Donepezil—Alzheimer's disease	0.000339	0.00166	CcSEcCtD
Labetalol—Urticaria—Rivastigmine—Alzheimer's disease	0.000338	0.00166	CcSEcCtD
Labetalol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000336	0.00165	CcSEcCtD
Labetalol—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000336	0.00165	CcSEcCtD
Labetalol—Diarrhoea—Donepezil—Alzheimer's disease	0.000328	0.00161	CcSEcCtD
Labetalol—Hypersensitivity—Memantine—Alzheimer's disease	0.000321	0.00157	CcSEcCtD
Labetalol—Dizziness—Donepezil—Alzheimer's disease	0.000317	0.00155	CcSEcCtD
Labetalol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000314	0.00154	CcSEcCtD
Labetalol—Fenoprofen—PTGS1—Alzheimer's disease	0.000313	0.0524	CrCbGaD
Labetalol—Asthenia—Memantine—Alzheimer's disease	0.000312	0.00153	CcSEcCtD
Labetalol—Pruritus—Memantine—Alzheimer's disease	0.000308	0.00151	CcSEcCtD
Labetalol—Asthenia—Rivastigmine—Alzheimer's disease	0.000305	0.0015	CcSEcCtD
Labetalol—Vomiting—Donepezil—Alzheimer's disease	0.000305	0.00149	CcSEcCtD
Labetalol—Rash—Donepezil—Alzheimer's disease	0.000302	0.00148	CcSEcCtD
Labetalol—Dermatitis—Donepezil—Alzheimer's disease	0.000302	0.00148	CcSEcCtD
Labetalol—Pruritus—Rivastigmine—Alzheimer's disease	0.000301	0.00148	CcSEcCtD
Labetalol—Headache—Donepezil—Alzheimer's disease	0.0003	0.00147	CcSEcCtD
Labetalol—Diarrhoea—Memantine—Alzheimer's disease	0.000298	0.00146	CcSEcCtD
Labetalol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000291	0.00143	CcSEcCtD
Labetalol—Dizziness—Memantine—Alzheimer's disease	0.000288	0.00141	CcSEcCtD
Labetalol—Formoterol—CYP2D6—Alzheimer's disease	0.000285	0.0478	CrCbGaD
Labetalol—Arformoterol—CYP2D6—Alzheimer's disease	0.000285	0.0478	CrCbGaD
Labetalol—Nausea—Donepezil—Alzheimer's disease	0.000285	0.0014	CcSEcCtD
Labetalol—Dizziness—Rivastigmine—Alzheimer's disease	0.000281	0.00138	CcSEcCtD
Labetalol—Vomiting—Memantine—Alzheimer's disease	0.000277	0.00136	CcSEcCtD
Labetalol—Rash—Memantine—Alzheimer's disease	0.000274	0.00135	CcSEcCtD
Labetalol—Dermatitis—Memantine—Alzheimer's disease	0.000274	0.00134	CcSEcCtD
Labetalol—Headache—Memantine—Alzheimer's disease	0.000273	0.00134	CcSEcCtD
Labetalol—Vomiting—Rivastigmine—Alzheimer's disease	0.000271	0.00133	CcSEcCtD
Labetalol—Rash—Rivastigmine—Alzheimer's disease	0.000268	0.00132	CcSEcCtD
Labetalol—Dermatitis—Rivastigmine—Alzheimer's disease	0.000268	0.00131	CcSEcCtD
Labetalol—Headache—Rivastigmine—Alzheimer's disease	0.000267	0.00131	CcSEcCtD
Labetalol—Nausea—Memantine—Alzheimer's disease	0.000258	0.00127	CcSEcCtD
Labetalol—Nausea—Rivastigmine—Alzheimer's disease	0.000253	0.00124	CcSEcCtD
Labetalol—Salsalate—PTGS2—Alzheimer's disease	0.000217	0.0363	CrCbGaD
Labetalol—Flurbiprofen—PTGS1—Alzheimer's disease	0.000204	0.0342	CrCbGaD
Labetalol—Tolterodine—CYP2D6—Alzheimer's disease	0.000187	0.0314	CrCbGaD
Labetalol—Ketoprofen—PTGS1—Alzheimer's disease	0.000185	0.031	CrCbGaD
Labetalol—Fenoprofen—PTGS2—Alzheimer's disease	0.000179	0.03	CrCbGaD
Labetalol—Propafenone—CYP2D6—Alzheimer's disease	0.000159	0.0267	CrCbGaD
Labetalol—Flurbiprofen—PTGS2—Alzheimer's disease	0.000117	0.0196	CrCbGaD
Labetalol—Ketoprofen—PTGS2—Alzheimer's disease	0.000106	0.0177	CrCbGaD
Labetalol—ADRB1—Signaling by GPCR—NPY—Alzheimer's disease	3.59e-05	0.000944	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PRKCG—Alzheimer's disease	3.59e-05	0.000943	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NPY—Alzheimer's disease	3.58e-05	0.000939	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IAPP—Alzheimer's disease	3.57e-05	0.000938	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IAPP—Alzheimer's disease	3.55e-05	0.000933	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—NPS—Alzheimer's disease	3.54e-05	0.00093	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—NPY—Alzheimer's disease	3.52e-05	0.000923	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IAPP—Alzheimer's disease	3.49e-05	0.000917	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CRH—Alzheimer's disease	3.47e-05	0.00091	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—GAB2—Alzheimer's disease	3.45e-05	0.000907	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—SST—Alzheimer's disease	3.45e-05	0.000907	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CRH—Alzheimer's disease	3.45e-05	0.000906	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CCR5—Alzheimer's disease	3.4e-05	0.000894	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CRH—Alzheimer's disease	3.39e-05	0.000891	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CDK5—Alzheimer's disease	3.38e-05	0.000888	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—F2—Alzheimer's disease	3.38e-05	0.000887	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—GAB2—Alzheimer's disease	3.38e-05	0.000887	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—SST—Alzheimer's disease	3.38e-05	0.000887	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—APP—Alzheimer's disease	3.36e-05	0.000884	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HTR2A—Alzheimer's disease	3.33e-05	0.000875	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CDK5—Alzheimer's disease	3.31e-05	0.000868	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—F2—Alzheimer's disease	3.3e-05	0.000868	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—APP—Alzheimer's disease	3.29e-05	0.000864	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—NPS—Alzheimer's disease	3.29e-05	0.000863	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NPS—Alzheimer's disease	3.27e-05	0.000859	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PPP3CA—Alzheimer's disease	3.27e-05	0.000859	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PPP3CA—Alzheimer's disease	3.26e-05	0.000855	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR6—Alzheimer's disease	3.25e-05	0.000855	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—F2—Alzheimer's disease	3.22e-05	0.000845	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—NPS—Alzheimer's disease	3.22e-05	0.000844	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PTK2B—Alzheimer's disease	3.21e-05	0.000842	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CA4—Alzheimer's disease	3.21e-05	0.000842	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PPP3CA—Alzheimer's disease	3.2e-05	0.00084	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR6—Alzheimer's disease	3.18e-05	0.000836	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PLCB1—Alzheimer's disease	3.18e-05	0.000834	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—SST—Alzheimer's disease	3.14e-05	0.000823	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—GAB2—Alzheimer's disease	3.14e-05	0.000823	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—GAB2—Alzheimer's disease	3.12e-05	0.000819	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SST—Alzheimer's disease	3.12e-05	0.000819	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NTRK2—Alzheimer's disease	3.12e-05	0.000819	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CALM1—Alzheimer's disease	3.11e-05	0.000816	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PLCB1—Alzheimer's disease	3.11e-05	0.000816	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—GSK3A—Alzheimer's disease	3.09e-05	0.000812	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—GAB2—Alzheimer's disease	3.07e-05	0.000805	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—SST—Alzheimer's disease	3.07e-05	0.000805	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—APP—Alzheimer's disease	3.06e-05	0.000802	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APP—Alzheimer's disease	3.04e-05	0.000799	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	3.01e-05	0.000791	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CCL2—Alzheimer's disease	3.01e-05	0.000791	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—APP—Alzheimer's disease	2.99e-05	0.000785	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PSENEN—Alzheimer's disease	2.95e-05	0.000776	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CCL2—Alzheimer's disease	2.95e-05	0.000773	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—F2—Alzheimer's disease	2.92e-05	0.000767	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APH1A—Alzheimer's disease	2.91e-05	0.000765	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PSENEN—Alzheimer's disease	2.89e-05	0.000759	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PLCB1—Alzheimer's disease	2.88e-05	0.000757	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PLCB1—Alzheimer's disease	2.87e-05	0.000754	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	2.86e-05	0.00075	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APH1A—Alzheimer's disease	2.85e-05	0.000748	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NCSTN—Alzheimer's disease	2.84e-05	0.000745	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PLCB1—Alzheimer's disease	2.82e-05	0.000741	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NCSTN—Alzheimer's disease	2.78e-05	0.000729	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LRP1—Alzheimer's disease	2.77e-05	0.000727	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PLD3—Alzheimer's disease	2.73e-05	0.000716	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	2.71e-05	0.000711	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	2.7e-05	0.00071	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	2.7e-05	0.00071	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NGFR—Alzheimer's disease	2.68e-05	0.000703	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CREB1—Alzheimer's disease	2.66e-05	0.000699	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	2.64e-05	0.000694	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	2.64e-05	0.000694	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ADAM10—Alzheimer's disease	2.62e-05	0.000687	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	2.61e-05	0.000686	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CCL2—Alzheimer's disease	2.6e-05	0.000684	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	2.52e-05	0.000661	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—S100B—Alzheimer's disease	2.47e-05	0.000649	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ND1—Alzheimer's disease	2.43e-05	0.000638	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	2.38e-05	0.000625	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IGF2—Alzheimer's disease	2.35e-05	0.000618	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	2.35e-05	0.000617	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	2.33e-05	0.000612	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	2.31e-05	0.000606	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	2.3e-05	0.000603	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IGF1R—Alzheimer's disease	2.28e-05	0.000598	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	2.26e-05	0.000593	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	2.23e-05	0.000584	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—LPL—Alzheimer's disease	2.18e-05	0.000573	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.18e-05	0.000572	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	2.18e-05	0.000572	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MEF2C—Alzheimer's disease	2.16e-05	0.000568	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	2.13e-05	0.00056	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.13e-05	0.000559	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	2.12e-05	0.000557	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PRKCG—Alzheimer's disease	2.12e-05	0.000557	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	2.11e-05	0.000554	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	2.09e-05	0.000548	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	2.08e-05	0.000545	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NGF—Alzheimer's disease	2.07e-05	0.000543	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	2.06e-05	0.000542	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	2.05e-05	0.000538	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	2.02e-05	0.000531	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCR5—Alzheimer's disease	2.01e-05	0.000528	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	2e-05	0.000526	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.98e-05	0.000519	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	1.98e-05	0.000519	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HTR2A—Alzheimer's disease	1.97e-05	0.000517	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	1.94e-05	0.00051	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.93e-05	0.000508	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.93e-05	0.000507	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	1.91e-05	0.000501	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	1.9e-05	0.0005	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	1.9e-05	0.000499	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.89e-05	0.000496	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	1.87e-05	0.00049	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	1.86e-05	0.000489	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SST—Alzheimer's disease	1.85e-05	0.000486	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	1.85e-05	0.000486	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	1.85e-05	0.000486	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	1.84e-05	0.000484	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	1.84e-05	0.000482	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CALM1—Alzheimer's disease	1.84e-05	0.000482	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—LEP—Alzheimer's disease	1.83e-05	0.00048	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APOE—Alzheimer's disease	1.83e-05	0.00048	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CAV1—Alzheimer's disease	1.81e-05	0.000476	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	1.81e-05	0.000476	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	1.81e-05	0.000476	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	1.81e-05	0.000476	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APP—Alzheimer's disease	1.81e-05	0.000474	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	1.8e-05	0.000474	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	1.8e-05	0.000472	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	1.77e-05	0.000464	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ESR1—Alzheimer's disease	1.75e-05	0.000459	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	1.73e-05	0.000455	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—F2—Alzheimer's disease	1.73e-05	0.000453	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	1.7e-05	0.000447	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	1.7e-05	0.000445	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NOTCH1—Alzheimer's disease	1.69e-05	0.000443	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	1.67e-05	0.000438	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	1.59e-05	0.000417	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—GSK3B—Alzheimer's disease	1.58e-05	0.000416	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	1.58e-05	0.000415	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CREB1—Alzheimer's disease	1.57e-05	0.000413	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.57e-05	0.000411	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.57e-05	0.000411	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—INS—Alzheimer's disease	1.56e-05	0.00041	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	1.55e-05	0.000408	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	1.55e-05	0.000408	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	1.55e-05	0.000406	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	1.54e-05	0.000406	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCL2—Alzheimer's disease	1.54e-05	0.000404	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	1.52e-05	0.000399	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IGF1—Alzheimer's disease	1.51e-05	0.000397	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	1.51e-05	0.000397	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.5e-05	0.000394	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	1.47e-05	0.000385	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.44e-05	0.000379	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	1.44e-05	0.000377	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	1.4e-05	0.000367	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—A2M—Alzheimer's disease	1.4e-05	0.000366	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NOS3—Alzheimer's disease	1.37e-05	0.00036	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	1.37e-05	0.000359	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	1.35e-05	0.000355	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	1.32e-05	0.000347	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	1.3e-05	0.00034	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	1.28e-05	0.000337	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	1.27e-05	0.000333	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	1.26e-05	0.000331	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	1.26e-05	0.00033	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	1.23e-05	0.000324	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	1.23e-05	0.000322	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ACHE—Alzheimer's disease	1.21e-05	0.000319	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	1.2e-05	0.000315	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	1.2e-05	0.000315	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	1.19e-05	0.000313	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.17e-05	0.000308	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	1.17e-05	0.000307	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	1.17e-05	0.000307	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CASP3—Alzheimer's disease	1.16e-05	0.000306	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL6—Alzheimer's disease	1.16e-05	0.000304	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	1.14e-05	0.0003	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	1.14e-05	0.000299	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ENO1—Alzheimer's disease	1.14e-05	0.000299	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	1.09e-05	0.000286	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	1.09e-05	0.000285	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	1.09e-05	0.000285	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	1.08e-05	0.000283	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MAPK8—Alzheimer's disease	1.07e-05	0.000281	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—AKT1—Alzheimer's disease	1.07e-05	0.00028	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	1.07e-05	0.00028	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	1.06e-05	0.000279	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	1.06e-05	0.000279	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—BCHE—Alzheimer's disease	1.06e-05	0.000278	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	1.05e-05	0.000276	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	1.04e-05	0.000272	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—F2—Alzheimer's disease	1.02e-05	0.000269	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	1.01e-05	0.000266	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	1e-05	0.000263	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	1e-05	0.000263	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	9.98e-06	0.000262	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—VEGFA—Alzheimer's disease	9.87e-06	0.000259	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	9.8e-06	0.000257	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	9.67e-06	0.000254	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	9.4e-06	0.000247	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	9.33e-06	0.000245	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	9.28e-06	0.000244	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	9.2e-06	0.000242	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	9.13e-06	0.00024	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	9.13e-06	0.00024	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	9.07e-06	0.000238	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TGFB1—Alzheimer's disease	9.06e-06	0.000238	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	8.97e-06	0.000236	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	8.93e-06	0.000234	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	8.78e-06	0.00023	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	8.34e-06	0.000219	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	8.3e-06	0.000218	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	8.14e-06	0.000214	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	7.96e-06	0.000209	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LPL—Alzheimer's disease	7.59e-06	0.000199	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TP53—Alzheimer's disease	7.46e-06	0.000196	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	6.97e-06	0.000183	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	6.91e-06	0.000181	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	6.86e-06	0.00018	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	6.83e-06	0.000179	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6—Alzheimer's disease	6.83e-06	0.000179	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	6.82e-06	0.000179	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	6.76e-06	0.000177	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	6.71e-06	0.000176	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CALM1—Alzheimer's disease	6.38e-06	0.000168	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOE—Alzheimer's disease	6.36e-06	0.000167	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	6.35e-06	0.000167	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	6.33e-06	0.000166	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CAV1—Alzheimer's disease	6.3e-06	0.000166	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AKT1—Alzheimer's disease	6.3e-06	0.000165	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	6.21e-06	0.000163	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	6.19e-06	0.000163	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	5.86e-06	0.000154	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	5.73e-06	0.000151	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARG—Alzheimer's disease	5.54e-06	0.000146	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—INS—Alzheimer's disease	5.43e-06	0.000143	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	5.38e-06	0.000141	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	5.26e-06	0.000138	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NOS3—Alzheimer's disease	4.77e-06	0.000125	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	4.43e-06	0.000116	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	4.36e-06	0.000114	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	4.33e-06	0.000114	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	4.05e-06	0.000106	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	3.97e-06	0.000104	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	3.74e-06	9.82e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	3.66e-06	9.61e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AKT1—Alzheimer's disease	2.19e-06	5.75e-05	CbGpPWpGaD
